Di Leo A - Search Results

1

Mechanisms of Resistance to CDK4/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice.

McCartney A, Migliaccio I, Bonechi M, Biagioni C, Romagnoli D, De Luca F, Galardi F, Risi E, De Santo I, Benelli M, Malorni L, Di Leo A. McCartney A, et al. Among authors: di leo a. Front Oncol. 2019 Jul 23;9:666. doi: 10.3389/fonc.2019.00666. eCollection 2019. Front Oncol. 2019. PMID: 31396487 Free PMC article. Review.

2

Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer.

Oakman C, Bessi S, Zafarana E, Galardi F, Biganzoli L, Di Leo A. Oakman C, et al. Among authors: di leo a. Breast Cancer Res. 2009;11(2):205. doi: 10.1186/bcr2238. Epub 2009 Apr 3. Breast Cancer Res. 2009. PMID: 19435470 Free PMC article. Review.

3

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.

Pestrin M, Bessi S, Galardi F, Truglia M, Biggeri A, Biagioni C, Cappadona S, Biganzoli L, Giannini A, Di Leo A. Pestrin M, et al. Among authors: di leo a. Breast Cancer Res Treat. 2009 Dec;118(3):523-30. doi: 10.1007/s10549-009-0461-7. Epub 2009 Jul 12. Breast Cancer Res Treat. 2009. PMID: 19597704

4

The role of topoisomerase IIalpha and HER-2 in predicting sensitivity to anthracyclines in breast cancer patients.

Oakman C, Moretti E, Galardi F, Santarpia L, Di Leo A. Oakman C, et al. Among authors: di leo a. Cancer Treat Rev. 2009 Dec;35(8):662-7. doi: 10.1016/j.ctrv.2009.08.006. Epub 2009 Sep 15. Cancer Treat Rev. 2009. PMID: 19758759 Review.

5

Adjuvant systemic treatment for individual patients with triple negative breast cancer.

Oakman C, Moretti E, Galardi F, Biagioni C, Santarpia L, Biganzoli L, Di Leo A. Oakman C, et al. Among authors: di leo a. Breast. 2011 Oct;20 Suppl 3:S135-41. doi: 10.1016/S0960-9776(11)70311-3. Breast. 2011. PMID: 22015281 Free article. Review.

6

Inter- and intra-tumoral heterogeneity in DNA damage evaluated by comet assay in early breast cancer patients.

Galardi F, Oakman C, Truglia MC, Cappadona S, Biggeri A, Grisotto L, Giovannelli L, Bessi S, Giannini A, Biganzoli L, Santarpia L, Di Leo A. Galardi F, et al. Among authors: di leo a. Breast. 2012 Jun;21(3):336-42. doi: 10.1016/j.breast.2012.02.007. Epub 2012 Mar 8. Breast. 2012. PMID: 22406214 Free article.

7

Polyendocrine treatment in estrogen receptor-positive breast cancer: a "FACT" yet to be proven.

Di Leo A, Malorni L. Di Leo A, et al. J Clin Oncol. 2012 Jun 1;30(16):1897-900. doi: 10.1200/JCO.2012.41.7394. Epub 2012 Apr 30. J Clin Oncol. 2012. PMID: 22547606 No abstract available.

8

Targeting triple negative breast cancer: is p53 the answer?

Turner N, Moretti E, Siclari O, Migliaccio I, Santarpia L, D'Incalci M, Piccolo S, Veronesi A, Zambelli A, Del Sal G, Di Leo A. Turner N, et al. Among authors: di leo a. Cancer Treat Rev. 2013 Aug;39(5):541-50. doi: 10.1016/j.ctrv.2012.12.001. Epub 2013 Jan 12. Cancer Treat Rev. 2013. PMID: 23321033 Review.

9

Adjuvant chemotherapy: which patient? What regimen?

Turner N, Biganzoli L, Malorni L, Migliaccio I, Moretti E, Pestrin M, Sanna G, Siclari O, Di Leo A. Turner N, et al. Among authors: di leo a. Am Soc Clin Oncol Educ Book. 2013:3-8. doi: 10.14694/EdBook_AM.2013.33.3. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714442 Free article.

10

The continued evidence from overviews: what is the clinical utility?

Turner N, Biganzoli L, Malorni L, Migliaccio I, Moretti E, Pestrin M, Sanna G, Siclari O, Di Leo A. Turner N, et al. Among authors: di leo a. Breast. 2013 Aug;22 Suppl 2:S8-11. doi: 10.1016/j.breast.2013.07.002. Breast. 2013. PMID: 24074798 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

781 results

Search Page